The Impact of Food on Gut Microbiome Composition - a Clinical Trial Determining the Influence of Diet in Gut Microbiome Colonisation and Host Health
NCT ID: NCT05986955
Last Updated: 2025-04-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
EARLY_PHASE1
25 participants
INTERVENTIONAL
2023-06-16
2023-11-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
* what is the the rate of gastrointestinal colonisation of food derived bacteria?
* what is the contribution of food derived bacteria to gut microbiome stability?
Participants will complete a cross over feeding study of dietitian designed meals of known microbial load and will be asked to provide stool and blood samples for analysis.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Metabolome and Microbiomic in Fecal Samples
NCT00938028
A Study to Evaluate the Influence of Diet on GI Health
NCT04783142
Multicentre Blinded Comparison of Lyophilized Sterile Fecal Filtrate to Lyophilized Fecal Microbiota Transplant in Recurrent Clostridioides Difficile Infection
NCT03806803
Mediterranean-like Unprocessed (CLEAN-MED) Diet Intervention Study of the Gut Microbiome of Healthy Adults
NCT05411120
Variability in Microbial Response to Dietary Fiber
NCT06023940
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
OTHER
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Specified Diet 1 - Microbial Diet
Participants provided with a typical Australian diet including all food groups as described by the Australian Guide to Healthy Eating without any dietary exclusions. Meals have been designed by researchers and dietitians and prepared by professional chefs.
Diet
Participants will be assigned prospectively to microbial or non-microbial diet for first phase of trial and will then cross over to the alternate diet following a washout period.
Specified Diet 2 - Non-microbial Diet
Diet provided to participants is identical to Specified Diet 1 however after cooking and packaging, food for this arm will be sterilised by irradiation in line with International Organisation for Standardisation (ISO) standards and Australian code of good manufacturing practice.
Diet
Participants will be assigned prospectively to microbial or non-microbial diet for first phase of trial and will then cross over to the alternate diet following a washout period.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Diet
Participants will be assigned prospectively to microbial or non-microbial diet for first phase of trial and will then cross over to the alternate diet following a washout period.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Not diagnosed with a significant medical conditions (e.g. irritable bowel syndrome, inflammatory bowel disease or type 1/2 diabetes)
* Do not require drug-therapy (e.g. steroids or insulin or antibiotics)
* Not taking dietary supplements, probiotics, prebiotics, symbiotics or fibre supplementation
* Any condition that will affect participation in the study
* Not pregnant, planning a pregnancy or breastfeeding
* Able to complete a two-month dietary study and agree to eating all meals provided
* Have no dietary allergies or dietary restrictions that prevent consumption of provided study meals
* Open bowels regularly - mostly daily
* Able to read, write and understand English
Exclusion Criteria
* Aged less than 18 years and older than 65 years
* Diagnosed with a medical condition that requires drug therapy
* Taking medications or supplements known to alter gastrointestinal microbiota
* Women who are pregnant, planning a pregnancy or breastfeeding
* Anyone with a diagnosed gastrointestinal condition/disease e.g. irritable bowel syndrome or inflammatory bowel disease
* Known dietary allergy and/or intolerance, follows a vegan or vegetarian diet, or has coeliac disease
* Anyone with a preference for specific food avoidance or exclusion of certain ingredients in habitual diet
* Unable to tolerate blood collection procedures
* Unable to provide regular stool samples throughout the study
18 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Monash University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dr. Sam Forster
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Dr. Sam Forster
Role: PRINCIPAL_INVESTIGATOR
Hudson Institue, Monash University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
BASE Facility
Notting Hill, Victoria, Australia
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RES-21-0000-602A
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.